πŸ‡ΊπŸ‡Έ FDA
Patent

US 11426486

Chitosan-containing formulations

granted A61KA61K31/722A61K45/06

Quick answer

US patent 11426486 (Chitosan-containing formulations) held by PRIMEX EHF expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRIMEX EHF
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/722, A61K45/06, A61K47/12, A61K9/0014